Laurus Labs Q4FY22 and Year Ended result : Profit surges down 22.31% to ₹230.50 Cr YoY

logo credit- laurus labs
article continues after this advertisement

Laurus Labs is an Indian multinational pharma and biotech company headquartered in Hyderabad, India with its manufacturing plants located at Visakhapatnam, Hyderabad and Bengaluru. Its focus areas include active pharma ingredients, finished dosage forms, synthesis and biotechnology. The company has posted its Q4FY22 and year ended financial results today, the details are as below :

(I) Audited Consolidated Financial Results for Quarter Ended (YoY comparison):

The company has reported, a consolidated Total Income of ₹1,426.12 crore in the quarter ended on March 31, 2022 as against ₹1,416.45 crore in the corresponding quarter ended last year on Mar 31, 2021, increased by 0.68%.

The company has posted a consolidated Net Profit of ₹230.50 crore in the quarter ended on March 31, 2022 as against ₹296.68 crore in the corresponding quarter ended in last year on Mar 31, 2021. The PAT surges down by 22.31%.

The status of the EPS of the company stood at ₹4.28 as on March 31, 2022 compared to the previous quarter ended on Mar 31, 2021 which was ₹5.5, down by 22.18%.

₹*Mar 31, 2022 (Q4FY22)Dec 31, 21 (Q3FY22)Mar 31, 21 (Q4)
Total Income1,426.121034.091,416.45
Total Expenses1124.41830.591015.28
PBT /(Loss)301.71203.50401.17
Total Tax /(credit)69.8148.53104.25
PAT /(Loss) [to the owners]230.50153.73296.68
*figures are in Crores

(II) Audited Consolidated Financial Result details for the Year Ended :

The company has reported, a consolidated Total Income of ₹4,950.87 crore in the financial year ended on March 31, 2022 as against ₹4,837.17 crore for the financial year ended on Mar 31, 2021, increased by 2.35%.

The company has posted a consolidated Net Profit of ₹827.52 crore in the financial year ended on March 31, 2022 as against ₹983.58 crore for the financial year ended on March 31, 2021. The PAT surges down by15.87 %.

The status of the EPS of the company stood at ₹15.35 as on March 31, 2022 compared to the previous year ended on March 31, 2021 which was ₹18.28, down by 16.03%.

₹*Mar 31, 2022 (FY22)Mar 31, 2021 (FY21)
Total Income4,950.874,837.17
Total Expenses3867.023536.06
PBT /(Loss)1083.851301.11
Total Tax /(credit)251.42317.29
PAT /(Loss)827.52983.58
*figures are in Crores

Shares of Laurus Labs Limited was last trading in BSE at ₹578.80 as compared to the previous close of ₹571.85. The total number of shares traded during the day was 71239 in over 2014 trades.

The stock of Laurus Labs last hit in BSE,

  • Intraday High of ₹ 585.10
  • Intraday low of ₹ 557.95